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Quality of life in patients with chronic venous
disease: San Diego population study
Robert M. Kaplan, PhD, Michael H. Criqui, MD, MPH, Julie O. Denenberg, MA, John Bergan, MD,
and Arnost Fronek, MD, San Diego, Calif
Background: Chronic venous disease in the lower extremities may have a substantial effect on functioning and quality of
life. We report quality of life data for an ethnically diverse population that had been systematically evaluated for venous
disease.
Subjects: Current and retired employees from a large public university were randomly selected within strata of age, sex, and
ethnicity. The sample included 2404 men and women ages 40 to 79 years.
Measures: Quality of life was measured with the Medical Outcomes Study 36-Item Short Form (SF-36). Venous disease
of the lower extremities was evaluated with two methods. Visual inspection was used to place participants into four
categories: normal, telangiectasias and spider veins, varicose veins, and trophic changes. Duplex ultrasound scanning was
used to place participants into three categories: normal, superficial venous disease, and deep vein disease.
Results: There were significant associations between quality of life and venous disease severity as assessed with both visual
and ultrasound methods. These differences were observed for both men and women for functional scales of the SF-36.
The relationships were significant, and were graded with degree of disease severity. Differences categories were not
statistically significant for the mental health scales of the SF-36.
Conclusion: Chronic venous disease in the lower extremities has a substantial effect on physical health aspects of quality
of life but not on mental health components. (J Vasc Surg 2003;37:1047-53.)
Chronic venous disease is a significant cause of morbid-
ity and mortality.1 Until recently, the epidemiology of
venous disease was poorly understood. There were few
population-based studies, and most studies used visual
inspection of the lower limbs rather than contemporary
noninvasive assessment with duplex ultrasound scanning. A
recent investigation2 of a multiethnic population reported
significantly more venous disease in women than in men,
but greater deep venous disease and trophic changes in
men. Both visual and functional venous disease increased
with advancing age, and the disease was more common in
non-Hispanic whites than in other ethnic groups. Although
there was an association between visual and functional
venous disease, the relationship was far from perfect.2
Despite the high prevalence of venous disease, the
effect on daily functioning and quality of life is still poorly
documented. Venous disease has been considered a cos-
metic problem that may affect emotional well-being. Ve-
nous disease affects selected aspects of daily functioning.3-6
An ad hoc committee of The Society for Vascular Surgery/
International Society for Vascular Surgery recommended
expansion of outcome measures in studies of venous disease
to include patient-reported measures of functioning and
quality of life.7 In their review, the committee noted that
comprehensive evaluation of venous disease must include
assessment of clinical outcomes and quality of life7; how-
ever, only a limited number of studies that measured quality
of life in patients with venous disease could be found.8 At
least six previous studies have used the Medical Outcomes
Study 36-Item Short Form (SF-36) in patients with vari-
cose veins. With some exceptions,6,9 disease status in pa-
tients included in these studies was not well de-
scribed.3,4,10,11
We report the relationship between venous disease and
health-related quality of life as measured with SF-36.12
Venous disease was characterized by both visual inspection
and duplex ultrasound scanning in a representative sample.
METHODS
Subjects
Current and retired employees of the University of
California, San Diego (UCSD) were randomly selected
within strata defined by age, sex, and ethnicity and were
invited to participate in a study of venous disease. Age was
categorized as 40 to 49 years, 50 to 59 years, 60 to 69 years,
and 70 to 79 years. We intentionally selected more women
and persons in three specific ethnic minority groups, ie,
Hispanics, African-Americans, and Asians. Oversampling of
minorities enabled statistical power for contrasts by ethnic-
ity, and oversampling of women enabled additional power
for testing of women-specific hypotheses, eg, the effect of
parity. The spouse or significant other of each randomly
selected participant was also invited to participate in the
study, and some volunteers who had heard about the study
and asked to participate were also enrolled.
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The study design was cross-sectional. At the study visit
each participant was interviewed by trained interviewers
who used a standardized protocol for obtaining informa-
tion on demographics, lifestyle,13 and personal and family
medical history.
Clinical examination
Using a standardized protocol, trained technologists
measured height, weight, waist circumference, hip circum-
ference, and systolic and diastolic blood pressure. The
remainder of the examination focused on the vascular sys-
tem in the lower extremities. The venous examination
included visual inspection for visible disease with the sub-
ject standing, as well as photographic documentation of
major abnormalities. Each leg was examined in five ana-
tomic regions, ie, thigh, knee, calf, ankle, and foot, and an
inspection template was used to record simple telangiecta-
sia (spider veins), defined as longer than 3 cm; reticular
telangiectasia, defined as a web greater than 8 cm in diam-
eter; simple varicosity; and reticular varicosity, defined as
four or more interconnected varicose veins.
Also at the visual examination, note was made of
evidence of trophic changes, ie, hyperpigmentation, li-
podermatosclerosis, or healed or active ulcer, at the level
of the calf or below. The presence of edema at the level of
the calf or below was also recorded, but was not consid-
ered a trophic change. Thirty-two limbs had active or
healed ulcers, nearly all at the malleolar level, and all but
one limb demonstrated venous disease at duplex scan-
ning.
Table I. Demographic characteristics of study cohort
Study cohort Visible disease Functional disease
n % NL TSV VV TCS NL SVD DVD
All subjects 2404 100.0 18.2 51.3 24.2 6.3 70.9 19.4 9.7
Sex Men 824 34.3 33.1 43.1 15.9 7.9 74.4 13.6 12.0
Women 1580 65.7 10.4 55.6 28.5 5.4 69.1 22.5 8.5
Age (y) 50 603 25.1 30.4 48.9 18.4 2.3 80.6 11.8 7.6
50-59 650 27.0 21.7 52.9 21.2 4.2 76.8 15.1 8.2
60-69 596 24.8 12.3 52.0 27.2 8.6 64.9 24.2 10.9
70 555 23.1 7.2 51.4 30.8 10.6 59.8 27.8 12.4
Ethnicity NHW 1436 59.7 13.6 54.2 25.3 7.0 68.3 20.5 11.2
Hispanic 353 14.7 18.7 49.6 27.2 4.5 70.5 23.2 6.2
African American 323 13.4 27.2 45.8 20.7 6.2 76.8 16.4 6.8
Asian 292 12.2 30.1 45.6 19.2 5.1 77.4 13.0 9.6
NL, Normal; TSV, telangiectasias, spider veins; VV, varicose veins; TCS, trophic changes; SVD, superficial venous disease; DVD, deep vein disease; NHW,
non-Hispanic white.
Table II. Summary of SF-36 scores by visible disease category
Visible venous
disease n
Physical functioning Role physical Pain index General health perceptions
Mean SD Mean SD Mean SD Mean SD
Physical health scales
Normal 388 51.47 8.43 50.98 9.40 50.85 9.39 52.36 8.33
TSV 1170 49.43 9.19 50.68 9.25 50.02 8.89 52.43 8.25
VV 553 48.65 9.13 48.88 10.48 48.87 9.40 52.03 8.26
TCS 146 44.77 10.49 45.13 11.42 46.77 9.65 49.47 9.48
Total 2257 49.28 9.26 49.93 9.85 49.67 9.20 52.12 8.38
Visible venous
disease n
Vitality Social functioning Role-emotional Mental health
Mean SD Mean SD Mean SD Mean SD
Mental health scales
Normal 388 52.71 8.73 52.05 8.95 52.03 8.28 52.50 8.52
TSV 1170 52.66 8.47 52.50 8.27 51.57 8.55 53.06 7.65
VV 553 52.26 8.79 51.92 8.45 51.19 9.13 52.93 7.50
TCS 146 50.57 8.14 50.71 9.16 50.69 8.86 53.16 7.22
Total 2257 52.43 8.59 52.16 8.50 51.50 8.67 52.94 7.74
TSV, Telangiectasias, spider veins; VV, varicose veins; TCS, trophic changes.
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Ultrasound examination
Both the superficial and deep venous systems were
examined for reflux and obstruction with an Acuson Model
128 duplex ultrasonographic scanner with a 5 MHz trans-
ducer. Duplex scanning measurements were recorded at
preselected anatomic levels with the subjects on a tilt table
in a 15-degree reverse Trendelenberg position, with the
legs slightly flexed in minimal external rotation. A probe
was used to determine vein wall compressibility with the
patient at rest. Standardized pressure with an automatic
cuff inflator (Hokanson, Bellevue, Wash), with rapid infla-
tion and deflation of cuffs placed sequentially at mid-thigh,
mid-calf, and foot level, was used to identify reflux. For
Valsalva reflux testing, a pressure monitoring system was
used to maintain 40 mm Hg of pressure for 3 seconds of
subject effort.
Reflux duration more than 0.5 seconds or Valsalva
reflux more than 0.5 seconds was considered evidence of
valvular insufficiency.14 Duration of reflux was a quantita-
tive estimate of severity of valvular incompetence. Partial
and complete venous obstruction were assessed by degree
of compressibility of venous walls, where complete com-
pressibility was normal.15,16 The reproducibility of these
measurements has been published.17 Four Registered Vas-
cular Technicians were employed during the course of our
4-year study. All were specifically trained in the protocol,
and adherence to the protocol was regularly monitored.
Reproducibility data have been published.17
We also recorded measurements of venous augmenta-
tion and disease phase for each subject, but because norma-
tive data have not been published for these measures, they
were not used in clinical diagnosis.
For all study procedures, participants provided signed
informed consent after a detailed introduction to the study.
The study was approved by the UCSD Committee on
Investigations Involving Human Subjects.
Disease classification
Visible categories. Visible classification was made be-
fore and thus independent of duplex scanning, and was
based on visual inspection of each leg separately. Four
hierarchical categories were established: normal, telangiec-
tasia or spider veins (TSV), varicose veins (VV), and trophic
changes (TCS). Thus normal legs were free of TSV, VV, or
TCS; the TSV category was free of VV and TCS; the VV
category may or may not have had TSV, but was free of
TCS; and the TCS category may or may not have had TSV
or VV. Legs visibly normal but with a history of sclerother-
apy were arbitrarily classified as TSV (n  7), and legs
normal or with visible TSV with a history of vein stripping
were classified as VV (n  23).
This classification parallels the recent consensus CEAP
document.18 Normal corresponds to class 0, TSV to class 1,
VV to class 2, and TCS to classes 4 to 6.
Functional categories. Functional classification was
made independent of visible findings with the Duplex
scanning criteria noted. The initial hierarchical classifica-
tion was normal, superficial venous disease (SVD), perfora-
tor disease, and deep venous disease (DVD). SVD was
defined as reflux or abnormal compression, ie, partial or
complete obstruction, in the long or short saphenous veins
or at the saphenofemoral junction, including Valsalva chal-
lenge or the saphenopopliteal junction, or in another su-
perficial vein, as noted by a technologist. Reflux in a perfo-
rating vein defined an abnormal perforator. DVD was
defined as reflux or abnormal compression in the common
femoral vein, including Valsalva challenge, or in the super-
ficial femoral, popliteal, or posterior tibial veins, or abnor-
mal compression at the peroneal vein.
Initial data analyses showed that less than 1% of all
examined legs had perforator abnormalities without DVD,
and these legs were grouped with SVD, leaving three
Fig 1. SF-36 scores by visual category for physical health scores
(top) and mental health scores (bottom).
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hierarchical functional categories, ie, normal, SVD, and
DVD. Inasmuch as there were few cases of isolated obstruc-
tion in either the SVD (0.4% of cases) or DVD (3.8% of
cases) group, these were not analyzed separately. Legs
functionally normal with a history of vein stripping were
arbitrarily classified as SVD (n  23).
These functional categories correspond to a combina-
tion of the CEAP anatomic (superficial, deep, and perforat-
ing veins) and pathophysiologic (reflux, obstruction, or
both) classifications.18
Quality of life assessment
All subjects completed SF-36. This form was the result
of work by the Rand Corporation and the Medical Out-
comes Study.12 The SF-36 includes eight health concepts:
physical functioning, role-physical, bodily pain, general
health perceptions, vitality, social functioning, role-emo-
tional, and mental health.19 The eight subscales can be
summarized into a physical component score (PCS) and a
mental component score (MCS). The reliability and valid-
ity of SF-36 are well documented,12,20,21 and it is the most
commonly used measure of quality of life in contemporary
medicine.
Statistical methods
Data were entered into a relational data base created
with screens that reflected the paper forms. The screens
included range and validity checks. Descriptive analyses
were conducted to look for outliers, and these were adju-
dicated against the original record. Statistical analyses were
conducted in SPSS 10.0 (SPSS, Chicago, Ill). Differences
between means were tested with one-way analysis of vari-
ance with planned comparisons for linear contrasts. Multi-
variate analysis was performed with analysis of covariance
models. All P values are based on two-tailed tests.
RESULTS
Demographic characteristics of the study population
are summarized in Table I. The study sample was approxi-
mately 60% non-Hispanic white, 15% Hispanic, 13% Afri-
can American, and 12% Asian. Participants were about
equally distributed in the age categories: younger than 50
years, 50 to 59 years, 60 to 69 years, and 70 years or older.
Table I also shows that more women had visible venous
disease than men did.
Scores for the four physical health components of SF-
36, broken down by visible disease categories, are summa-
rized in the top part of Table II, and scores for the mental
health components of SF-36 are shown in the bottom part
of the table. The same information is shown graphically in
the top panel of Fig 1. Differences between visual catego-
ries of disease were highly significant, with a strong linear
component for the physical health subscales of SF-36. In
particular, there were strong linear effects for Physical
Functioning (F1/2245  52.20; P  .0001), Role-Physical
(F1/2245 41.98; P .0001), Pain (F1/2245 25.43; P
.0001), and General Health Perception (F1/2245  8.45;
P  .001) scales. The bottom panel of Fig 1 shows the
analysis for the mental health or well-being scales of SF-36.
The only significant effect was for Vitality, which was
relatively weak in relation to other SF-36 functional scales
(F1/2244  5.28; P  .03).
Similar trends were observed for the functional catego-
ries based on duplex ultrasound scanning evaluations.
However, these trends were not so strong as for the visual
categories (Table 3; Figure 2). The overall F scores were
statistically significant, and there were strong linear trends
for all four SF-36 physical health scales (df for all tests,
1/2253; Physical Functioning, F  9.74, P  .01; Role-
Physical, F  23.18, P  .001; Pain, F  6.85, P  .01;
Table III. Summary of SF-36 scores by functional disease category
Functional venous
disease n
Physical
functioning Role-physical Pain index
General health
perceptions
Mean SD Mean SD Mean SD Mean SD
Physical health scales
Normal 1596 49.73 9.23 50.61 9.37 50.11 9.06 52.37 8.40
SVD 446 48.12 9.38 48.30 10.61 48.21 9.42 52.17 8.13
DVD 215 48.41 8.92 48.20 11.02 49.45 9.50 50.23 8.45
Total 2257 49.28 9.26 49.93 9.85 49.67 9.20 52.12 8.38
Functional venous
disease n
Vitality Social functioning Role-emotional Mental health
Mean SD Mean SD Mean SD Mean SD
Mental health scales
Normal 1596 52.60 8.60 52.26 8.60 51.61 8.58 52.86 7.94
SVD 446 51.86 8.63 52.12 8.01 51.23 8.74 53.23 8.74
DVD 215 52.38 8.39 51.54 8.77 51.20 9.17 52.95 8.11
Total 2257 52.43 8.59 52.16 8.50 51.50 8.67 52.94 7.74
SVD, superficial venous disease; DVD, deep venous disease.
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General Health Perceptions, F  9.34, P  .001). Similar
trends were not observed for any mental health scores, and
all differences between groups and linear trends were non-
significant.
The analyses were repeated with adjustment for gender
and ethnicity. Age was significantly negatively correlated
with PCS (r  0.26; P  .001) but positively correlated
with MCS (r  0.178; P  .001) SF-36 summary compo-
nent scores. This suggests that older participants had lower
physical health scores but slightly higher mental health
scores. Men had significantly higher PCS summary scores
than did women (P .01) and marginally higher scores on
the MCS summary dimensions (P  .10). There were also
significant differences in SF-36 summary scores by ethnic-
ity; the Asian group scored highest on both PCS and MCS
components. For the MCS component, the white non-
Hispanic group had the lowest mean score. Despite the
univariate effects of age, gender, and ethnicity, adjustments
for these variables did not affect the results for either visual
category or ultrasound category. This suggests that differ-
ences in quality of life are explained primarily by disease
category. Ethnicity, age, and gender contribute to predic-
tion of quality of life, but independent of disease category.
A final set of analyses examined the effect of visual
category with adjustment for ultrasound category, and the
effect of ultrasound category with adjustment for visual
category. These analyses focused on PCS and MCS sum-
mary scores. Using a general linear model, we observed
strong differences in PCS by visual category (F1/2211 
35.15; P  .001). However, when visual category was
entered, ultrasound category did not explain additional
variance (P  .74). The model entering the ultrasound
categories with the visual category as a covariate still fa-
vored the visual category. These findings suggest that the
visual categories explain most of the variance in SF-36
physical component scores. In the MCS model, differences
between both the visual and ultrasound categories were
nonsignificant, and adjustments did not have significant
effects.
DISCUSSION
In an epidemiologic study we evaluated venous disease
with visual and functional criteria.2 Venous disease of the
lower extremities is the most common vascular dis-
ease.1,17,22 Identification of disease with visual inspection is
substantially correlated with identification with duplex ul-
trasound scanning. We searched the PubMed database in
fall 2002, using the key words “venous disease” and “qual-
ity of life.” The search identified 139 articles. Among these,
many were not directly related to venous disease. For
example, several papers dealt with other issues, eg, pain in
gynecology clinics. Further, the number of papers report-
ing original data were limited. The PubMed search identi-
fied only four studies that used SF-36. Only a few studies
have considered the effect of venous disease of the lower
extremities on functioning and quality of life.3,5,6,9-11,23
Evidence from our study indicates that even modest venous
disease translates into functional limitations and limitations
in daily activities.
The SF-36 includes eight subscales. These subscales
have been factor analyzed and clustered into two groups:
physical and mental health.12 Physical health components
are regarded as measures of functioning, whereas mental
health components are thought of as indicators of well-
being. Functioning describes what a person is able to do;
well-being characterizes how a person feels, particularly on
mental health or emotional dimensions. Evidence from this
study suggests that venous disease affects the functional
scales (what a person can do) but does not seem to affect
the well-being aspects (how a person feels). Similar results
were reported in a recent European study. Kurz et al9 also
found significant gradations in SF-36 PCS scores by disease
Fig 2. SF-36 scores by ultrasound category for physical health
scores (top) and mental health scores (bottom).
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severity, but found few differences for MCS components.
An alternative explanation for our findings is that MCS
subscales are not sensitive to emotional domains in this
population. Although this remains a possibility, it is worth
noting that SF-36 MCS scale is well-validated and sensitive
to expected mental health variations in several popula-
tions.12,21 In addition to evidence suggesting that quality
of life measures are associated with disease severity, some
evidence suggests that the measures are also responsive to
changes after therapeutic intervention.11 For example, the
MCS component changes significantly after treatment for
depression and back pain and after hip replacement.24
Long saphenous vein stripping appears unrelated to quality
of life, as measured with SF-36.25
These findings have implications for understanding
venous disease. Some believe that venous disease is a cos-
metic problem and that its major effects are on appearance,
self-esteem, and emotional health. Our findings suggest
that the effects of venous disease are on the functional
aspects of quality of life and not on the emotional compo-
nents. Combined with evidence that venous disease causes
considerable morbidity,1 our data imply that venous disease
of the lower extremities is more than a cosmetic problem.
Results of this study should be interpreted in light of
several limitations. First, the study concentrated on univer-
sity employees rather than a random sample of the general
population. UCSD hires a wide cross-section of persons,
and the sample included all classes of employment. How-
ever, this is the largest study of quality of life in venous
disease yet reported. The study included more than 2257
participants, whereas most previous studies comprised only
a few hundred participants. The one study of comparable
size, ie, Kurz et al9 with 1936 participants, had a different
subject population but remarkably similar results. The sec-
ond concern is that there is some self-selection toward
participation in the quality of life component of the study.
The initial sample frame included 6115 employees, along
with their spouses or significant others. When the study
began, we used interviewer-administered measures. How-
ever, after the first 200 subjects had been interviewed it
became apparent that the procedure was too complex, and
a decision was made to switch to self-administered forms.
Only subjects willing to fill out and return SF-36 on their
own were included. There were 2408 participants willing to
complete this aspect of the study. Four participants did not
complete the duplex scanning examination, leaving 2404
who completed the epidemiologic study. Although there
was some selective participation, we have no reason to
believe there is systematic bias in the loss of participants,
and we encourage replication.
In summary, venous disease of the lower extremities is
a prevalent condition. The health consequences of venous
disease are not fully understood, but it is clear that it
increases risk for venous thrombotic events, which can be
fatal. Even modest venous disease is associated with signif-
icant limitations on the functional scales of SF-36. Venous
disease does not appear to affect emotional aspects of
health-related quality of life.
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